Common adverse drug reactions (ADRs) associated with<unk>  therapy include central nervous system stimulation, insomnia, nervousness, excitability, dizziness and anxiety. Infrequent ADRs include tachycardia or palpitations. Rarely,<unk>  therapy may be associated with mydriasis (dilated pupils), hallucinations, arrhythmias, hypertension, seizures and ischemic colitis; as well as severe skin reactions known as recurrent<unk> udo-scarlatina, systemic contact dermatitis, and nonpigmenting fixed drug eruption.<unk> , particularly when combined with other drugs including narcotics, may also play a role in the precipitation of episodes of paranoid psychosis. It has also been reported that<unk> , among other sympathomimetic agents, may be associated with the occurrence of stroke. Precautions and contraindications<unk>  is contraindicated in patients with diabetes mellitus, cardiovascular disease, severe or uncontrolled hypertension, severe coronary artery disease, prostatic hypertrophy, hyperthyroidism, closed angle glaucoma, or by pregnant women. The safety and effectiveness of nasal decongestant use in children is unclear.
Pseudoephedrine
Ephedrine
Theobromine
Tesofensine
Benzoctamine
Bethanechol
Butalbital
Guaifenesin